BACKGROUND: Despite widespread popularity and possible health effects, the prevalence and distribution of coffee consumption in US adults are poorly characterized. OBJECTIVE: We sought to estimate usual daily coffee intakes from all coffee-containing beverages, including decaffeinated and regular coffee, among US adults according to demographic, socioeconomic, and health-related factors. METHODS: Dietary intake data from ≤2 nonconsecutive 24-h dietary recalls and a food-frequency questionnaire administered during the NHANES 2003-2006 were used to estimate the person-specific probability of consuming coffee on a particular day and the usual amount consumed on consumption days. Trends in population mean coffee consumption over time were evaluated by using multiple linear regression and 1-d 24-h recall data from NHANES 2003-2012. Analyses were weighted to be representative of the US adult population aged ≥20 y. RESULTS: An estimated 154 million adults, or 75% of the US population, aged ≥20 y reported drinking coffee; 49% reported drinking coffee daily. Prevalence did not vary by sex, education, income, or self-reported general health (all P ≥ 0.05) but did vary by age, race/ethnicity, smoking status, and alcohol drinking (all P < 0.05). Among coffee drinkers, the mean ± SE usual intake was 14.1 ± 0.5 fluid ounces/d (417 ± 15 mL/d). Mean usual intakes were higher in men than women, in older age groups than in those aged 20 to <30 y, in non-Hispanic whites than in non-Hispanic blacks or Hispanic/other races, in smokers than in never smokers, and in daily alcohol consumers than in nonconsumers (all P < 0.05). Population mean coffee consumption was stable from 2003 to 2012 (P-trend = 0.09). CONCLUSIONS: Coffee is widely consumed in the United States, with usual intakes varying by lifestyle and demographic factors, most notably by age. Longitudinal studies are needed to determine whether observed differences by age reflect birth cohort effects or changes in drinking patterns over the lifetime.
BACKGROUND: Despite widespread popularity and possible health effects, the prevalence and distribution of coffee consumption in US adults are poorly characterized. OBJECTIVE: We sought to estimate usual daily coffee intakes from all coffee-containing beverages, including decaffeinated and regular coffee, among US adults according to demographic, socioeconomic, and health-related factors. METHODS: Dietary intake data from ≤2 nonconsecutive 24-h dietary recalls and a food-frequency questionnaire administered during the NHANES 2003-2006 were used to estimate the person-specific probability of consuming coffee on a particular day and the usual amount consumed on consumption days. Trends in population mean coffee consumption over time were evaluated by using multiple linear regression and 1-d 24-h recall data from NHANES 2003-2012. Analyses were weighted to be representative of the US adult population aged ≥20 y. RESULTS: An estimated 154 million adults, or 75% of the US population, aged ≥20 y reported drinking coffee; 49% reported drinking coffee daily. Prevalence did not vary by sex, education, income, or self-reported general health (all P ≥ 0.05) but did vary by age, race/ethnicity, smoking status, and alcohol drinking (all P < 0.05). Among coffee drinkers, the mean ± SE usual intake was 14.1 ± 0.5 fluid ounces/d (417 ± 15 mL/d). Mean usual intakes were higher in men than women, in older age groups than in those aged 20 to <30 y, in non-Hispanic whites than in non-Hispanic blacks or Hispanic/other races, in smokers than in never smokers, and in daily alcohol consumers than in nonconsumers (all P < 0.05). Population mean coffee consumption was stable from 2003 to 2012 (P-trend = 0.09). CONCLUSIONS: Coffee is widely consumed in the United States, with usual intakes varying by lifestyle and demographic factors, most notably by age. Longitudinal studies are needed to determine whether observed differences by age reflect birth cohort effects or changes in drinking patterns over the lifetime.
Authors: Erikka Loftfield; Neal D Freedman; Barry I Graubard; Kristin A Guertin; Amanda Black; Wen-Yi Huang; Fatma M Shebl; Susan T Mayne; Rashmi Sinha Journal: Am J Epidemiol Date: 2015-11-27 Impact factor: 4.897
Authors: Neal D Freedman; Yikyung Park; Christian C Abnet; Albert R Hollenbeck; Rashmi Sinha Journal: N Engl J Med Date: 2012-05-17 Impact factor: 91.245
Authors: Erikka Loftfield; Neal D Freedman; Barry I Graubard; Albert R Hollenbeck; Fatma M Shebl; Susan T Mayne; Rashmi Sinha Journal: J Natl Cancer Inst Date: 2015-01-20 Impact factor: 13.506
Authors: Victor Kipnis; Douglas Midthune; Dennis W Buckman; Kevin W Dodd; Patricia M Guenther; Susan M Krebs-Smith; Amy F Subar; Janet A Tooze; Raymond J Carroll; Laurence S Freedman Journal: Biometrics Date: 2009-12 Impact factor: 2.571
Authors: G Y Lai; S J Weinstein; D Albanes; P R Taylor; K A McGlynn; J Virtamo; R Sinha; N D Freedman Journal: Br J Cancer Date: 2013-07-23 Impact factor: 7.640
Authors: Brandilyn A Peters; Marjorie L McCullough; Mark P Purdue; Neal D Freedman; Caroline Y Um; Susan M Gapstur; Richard B Hayes; Jiyoung Ahn Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-04-27 Impact factor: 4.254
Authors: Emily A Hu; Elizabeth Selvin; Morgan E Grams; Lyn M Steffen; Josef Coresh; Casey M Rebholz Journal: Am J Kidney Dis Date: 2018-03-20 Impact factor: 8.860
Authors: Jihye Park; Joseph B Stanford; Christina A Porucznik; Kylie Christensen; Karen C Schliep Journal: Psychoneuroendocrinology Date: 2019-09-16 Impact factor: 4.905
Authors: Song-Yi Park; Neal D Freedman; Christopher A Haiman; Loïc Le Marchand; Lynne R Wilkens; Veronica Wendy Setiawan Journal: Ann Intern Med Date: 2017-07-11 Impact factor: 25.391